Location History:
- Pittsburg, KS (US) (2021)
- Orlando, FL (US) (2012 - 2022)
Company Filing History:
14 out of 1,310 
2 out of 2 
2 out of 560 
Years Active: 2012-2025
Title: **Innovative Contributions of Inventor Santimukul Santra in Nanotechnology**
Introduction
Santimukul Santra is an accomplished inventor based in Orlando, FL, known for his significant contributions to the field of nanotechnology. With an impressive portfolio of 14 patents, Santra has pioneered innovative methods and compositions that aim to revolutionize cancer treatment and diagnosis.
Latest Patents
Among his latest patents is the development of **bi-dota complex-loaded dendritic polymer nanoparticles**. These compositions are designed to include polymeric nanoparticles that can be conjugated with targeting ligands specific to solid tumor cell proteins. The hydrophobic interior of these nanoparticles is capable of encasing imaging compounds and therapeutic agents, allowing for targeted delivery to cancer cells. This breakthrough offers potential in identifying and treating solid tumor targets, particularly lung cancer.
Another noteworthy patent consists of **methods and compositions for theranostic nanoparticles**. This invention focuses on a nanoparticle that utilizes a hyperbranched polyester (HBPE) with a hydrophobic core. The nanoparticle features polyglutamate folate ligands and includes one or more positron emission tomography (PET) detectable isotopes, enhancing its effectiveness in drug delivery and diagnostic applications.
Career Highlights
Throughout his career, Santimukul Santra has made pivotal strides in the medical research sector. He has worked with reputable institutions such as the University of Central Florida Research Foundation, Inc. and the Sanford Burnham Prebys Medical Discovery Institute at Lake Nona, further enriching his expertise in innovation and application of nanotechnology in medicine.
Collaborations
Santra's impactful work has been complemented by valuable collaborations with distinguished colleagues, including Charalambos Kaittanis and Jesus Manuel Perez. Their shared expertise has contributed to the advancement of his research initiatives, fostering innovation in cancer therapeutics.
Conclusion
With a groundbreaking career marked by significant patents and collaborations, Santimukul Santra continues to be a leading figure in the field of nanotechnology. His innovations offer hope for more effective cancer treatments and diagnostic solutions, showcasing the transformative power of technology in healthcare.